La Transition Épithélio-Mésenthymateuse (TEM), marqueur prédictif d’évolution de NCA ?Epithelial-mesenchymal transition of the renal graft
Références (9)
- et al.
Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies
Kidney Int
(2002) - et al.
Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis
Am J Transplant
(2005) - et al.
Risk factors for early epithelial to mesenchymal transition in renal grafts
Am J Transplant
(2006) Marrow stromal cells as stem cells for nonhematopoietic tissues
Science
(1997)
There are more references available in the full text version of this article.
Cited by (6)
Adenovirus-mediated anti-sense ERK2 gene therapy inhibits tubular epithelial-mesenchymal transition and ameliorates renal allograft fibrosis
2011, Transplant ImmunologyCitation Excerpt :In renal fibrosis study, the role of myofibroblasts (mesenchymal cells) has been widely accepted, but their origins and activation process remain largely controversial [7], especially undefined on renal allograft. To date, accumulating data show that Epithelial–mesenchymal transition (EMT) plays an important role in the progress of renal fibrogenesis [7–9]. Tubular EMT, by definition, is a process in which renal tubular cells lose their epithelial phenotype and acquire new features of mesenchyme, including four key events: loss of epithelial adhesion properties, de novo expression of α-smooth muscle actin (α-SMA) and actin reorganization, disruption of tubular basement membrane, and enhanced cell migration and invasion [10].
Role of matrix metalloproteinases in degenerative kidney disorders
2017, Current Medicinal ChemistryTissue remodelling in chronic bronchial diseases: From the epithelial to mesenchymal phenotype
2014, European Respiratory ReviewTransforming growth factor beta 1 inhibits proliferation of human renal tubular epithelial cells
2013, Chinese Journal of Tissue Engineering ResearchA systems approach identifies HIPK2 as a key regulator of kidney fibrosis
2012, Nature MedicineMatrix metalloproteinases (MMPs) in renal fibrosis
2012, Matrix Metalloproteinases: Biology, Functions and Clinical Implications
Copyright © 2008 Elsevier Masson SAS. All rights reserved.